Prostate Cancer (Diagnosis)
36
19
19
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 36 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (36)
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
Theranostic Applications of Radionuclides in Prostate Cancer
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
Effects of Music Therapy on Anxiety and Distress Levels During Radionuclide Treatment in Prostate Cancer Patients
A Prospective Clinical Trial Evaluating PROSTest, a Blood-Based Molecular Assay, for Risk Stratification and Biopsy Decision Support in Men With Suspected Prostate Cancer
Turkish Version of the UCLA Prostate Cancer Index
Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging
PSMA PET for Surveillance After Focal Therapy
Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise
Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe